Adrenocortical secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; ☃↵

Adrenocortical carcinoma secondary prevention

• Patients should be followed at 3-month intervals after initial treatment for 2 to 3 years.

• Surveillance intervals may be increased to 6 months for the next 5 years.

• Surveillance should also include:
  • Cross-sectional imaging of chest, abdomen, and pelvis
  • The use of FDG-PET for lesions of an unclear nature
  • Laboratory evaluation for steroid hormones
  • Evaluation of side effects is also important in case of adjuvant mitotane therapy